Insights Ahead: Relmada Therapeutics's Quarterly Earnings

Relmada Therapeutics (NASDAQ:RLMD) is gearing up to announce its quarterly earnings on Thursday, 2025-03-27. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Relmada Therapeutics will report an earnings per share (EPS) of $-0.58.

Relmada Therapeutics bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for ...